The firm also reported a 46 percent increase in molecular biology sales due to growth in its FilmArray line.
The firm said that business agreements with IBM, Ancestry, and others will help it stay on track in meeting commitments for the year.
Professional, molecular, and tissue diagnostics sales continued to grow during the first three quarters, while diabetes care sales remained in decline.
The company's revenues were in line with analyst expectations, while its adjusted earnings per share of $.87 beat expectations.
The company sold 9.1 million shares of its common stock and warrants to purchase up to 9.1 million more shares at a combined offering price of $1.10 per share.
In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.
Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.
Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.
The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.